Skip to main
PLXS
PLXS logo

Plexus (PLXS) Stock Forecast & Price Target

Plexus (PLXS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Plexus Corp demonstrates a strong financial outlook, highlighted by a year-over-year revenue growth of 5% in its Healthcare Life Sciences segment, amounting to $1.629 billion for the full year, with positive momentum expected to continue into the first quarter. The company anticipates high-single-digit to low-double-digit growth in its Healthcare Life Sciences for FQ1, driven by the ramping of multiple programs and recovering customer demand. Additionally, the anticipated growth in the Aerospace and Defense segment, alongside the overall company-wide revenue growth goal of 9-12%, reinforces Plexus's strong market position and potential for sustained earnings leverage.

Bears say

Plexus Corp's gross margin experienced a decline to 9.9% from 10.1% in the previous quarter, indicating potential pressure on profitability regardless of matching operating margins. Revenue from the Aerospace & Defense segment, representing 16% of total revenue, decreased by 6% both quarter-over-quarter and year-over-year, signaling demand weakness in a key market. The forecast for Industrial revenues suggests a projected decline in the first quarter, reflecting seasonality and moderating demand amid broader economic slowdown risks and challenges in maintaining competitive differentiation.

Plexus (PLXS) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Plexus (PLXS) Forecast

Analysts have given Plexus (PLXS) a Buy based on their latest research and market trends.

According to 4 analysts, Plexus (PLXS) has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $157.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $157.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Plexus (PLXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.